Are there new treatments for multiple sclerosis on the horizon?
The answer is maybe. They are currently still in “testing” mode, but things look promising. This is great news for anyone with multiple sclerosis or anyone who knows anyone with this debilitating disease that tends to hit people in their younger years.
In a recent episode of Causes or Cures, I chatted with Dr. Ari Green about the latest thinking on what causes Multiple Sclerosis (MS) and who it impacts most, current treatment approaches, and research on potential new treatments for multiple sclerosis involving remylenation therapies. He chats about the ReBUILD trial and something called the “Myelin Water Fraction” and how it can be used to measure remylenation. He also discusses the latest evidence on preventive factors for MS. And don’t worry! I know I used a lot of “sciency” sounding words there, but he will break it down for us in the podcast. And some of the stuff you may not full get, but you will get the gist of the podcast…which is the important part. 🙂
Dr. Green is a neurologist and neuro-ophthalmologist and medical director of the UCSF Multiple Sclerosis Center. He is also director of the UCSF Neurodiagnostic Center. His research focus is on reparative treatments for people with MS and slowing down neurodegeneration. You can learn more about him here.
To tune into this episode, please click here.
And when you go to Causes or Cures, please check out some of the other podcast episodes too! I cover a wide range of health and public health topics, so maybe you’ll find something that strikes your fancy.
In addition to the podcast on new treatments for multiple sclerosis, check out this podcast on gene-drive mosquitoes here (sounds like a sci-fi novel, right?) or this one here on what we are ALL getting WRONG about misinformation.